HUMAN IMMUNOGLOBULINS
Post-polio Syndrome
Azienda Ospedaliera Universitaria Integrata Veronaother_biologicalPhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Post-polio Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) Instituto Grifols, S.A. | Phase 2/3 | CC |
Same molecule, other indications
HUMAN IMMUNOGLOBULINS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →